176 related articles for article (PubMed ID: 23108832)
1. Neurofibromatosis 2: hearing restoration options.
Monteiro TA; Goffi-Gomez MV; Tsuji RK; Gomes MQ; Brito Neto RV; Bento RF
Braz J Otorhinolaryngol; 2012 Oct; 78(5):128-34. PubMed ID: 23108832
[TBL] [Abstract][Full Text] [Related]
2. Auditory brainstem implants in NF2 patients: results and review of the literature.
Sanna M; Di Lella F; Guida M; Merkus P
Otol Neurotol; 2012 Feb; 33(2):154-64. PubMed ID: 22246383
[TBL] [Abstract][Full Text] [Related]
3. Cochlear implantation and auditory brainstem implantation in neurofibromatosis type 2.
Peng KA; Lorenz MB; Otto SR; Brackmann DE; Wilkinson EP
Laryngoscope; 2018 Sep; 128(9):2163-2169. PubMed ID: 29573425
[TBL] [Abstract][Full Text] [Related]
4. Comparing Speech Recognition Outcomes Between Cochlear Implants and Auditory Brainstem Implants in Patients With NF2-Related Schwannomatosis.
Dornhoffer JR; Plitt AR; Lohse CM; Driscoll CLW; Neff BA; Saoji AA; Van Gompel JJ; Link MJ; Carlson ML
Otol Neurotol; 2024 Jan; 45(1):29-35. PubMed ID: 37875011
[TBL] [Abstract][Full Text] [Related]
5. Auditory outcomes in tumor vs. nontumor patients fitted with auditory brainstem implants.
Colletti V
Adv Otorhinolaryngol; 2006; 64():167-185. PubMed ID: 16891842
[TBL] [Abstract][Full Text] [Related]
6. English consensus protocol evaluating candidacy for auditory brainstem and cochlear implantation in neurofibromatosis type 2.
Tysome JR; Axon PR; Donnelly NP; Evans DG; Ferner RE; O'Connor AF; Freeman SR; Gleeson M; Halliday D; Harris F; Jiang D; Kerr R; King A; Knight RD; Lloyd SK; Macfarlane R; Mannion R; Mawman D; O'Driscoll M; Parry A; Ramsden J; Ramsden R; Rutherford SA; Saeed SR; Thomas N; Vanat ZH
Otol Neurotol; 2013 Dec; 34(9):1743-7. PubMed ID: 24136318
[TBL] [Abstract][Full Text] [Related]
7. Auditory rehabilitation with cochlear implantation in patients with neurofibromatosis type 2.
Tran Ba Huy P; Kania R; Frachet B; Poncet C; Legac MS
Acta Otolaryngol; 2009 Sep; 129(9):971-5. PubMed ID: 19016361
[TBL] [Abstract][Full Text] [Related]
8. Impact of cochlear implantation on the management strategy of patients with neurofibromatosis type 2.
Tan H; Jia H; Li Y; Zhang Z; Zhu W; Cai Y; Wang Z; Wu H
Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2667-2674. PubMed ID: 30229456
[TBL] [Abstract][Full Text] [Related]
9. Cochlear implants in the management of hearing loss in Neurofibromatosis Type 2.
Harris F; Tysome JR; Donnelly N; Durie-Gair J; Crundwell G; Tam YC; Knight RD; Vanat ZH; Folland N; Axon P
Cochlear Implants Int; 2017 May; 18(3):171-179. PubMed ID: 28335700
[TBL] [Abstract][Full Text] [Related]
10. Hearing Rehabilitation in Patients With Neurofibromatosis Type 2: The Quebec's Experience With Auditory Implants.
Khneisser E; Bussieres R; Côté M; Philippon D; Fradet G; Côté M; Lessard N; Champagne PO; Trudel M
Otol Neurotol; 2023 Sep; 44(8):e621-e627. PubMed ID: 37550875
[TBL] [Abstract][Full Text] [Related]
11. Novel Statistical Analyses to Assess Hearing Outcomes After ABI Implantation in NF2 Patients: Systematic Review and Individualized Patient Data Analysis.
Taslimi S; Zuccato JA; Mansouri A; Hachem LD; Badhiwala J; Kuchta J; Chen J; Pirouzmand F
World Neurosurg; 2019 Aug; 128():e669-e682. PubMed ID: 31059859
[TBL] [Abstract][Full Text] [Related]
12. Auditory brainstem implants for neurofibromatosis type 2.
Colletti L; Shannon R; Colletti V
Curr Opin Otolaryngol Head Neck Surg; 2012 Oct; 20(5):353-7. PubMed ID: 22886036
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of cochlear implantation in patients with neurofibromatosis type 2.
North HJ; Mawman D; O'Driscoll M; Freeman SR; Rutherford SA; King AT; Hammerbeck-Ward C; Evans DG; Lloyd SK
Cochlear Implants Int; 2016 Jul; 17(4):172-177. PubMed ID: 27691934
[TBL] [Abstract][Full Text] [Related]
14. Pediatric Auditory Brainstem Implant Surgery: A New Option for Auditory Habilitation in Congenital Deafness?
Shah PV; Kozin ED; Kaplan AB; Lee DJ
J Am Board Fam Med; 2016; 29(2):286-8. PubMed ID: 26957388
[TBL] [Abstract][Full Text] [Related]
15. Auditory rehabilitation of patients with neurofibromatosis Type 2 by using cochlear implants.
Roehm PC; Mallen-St Clair J; Jethanamest D; Golfinos JG; Shapiro W; Waltzman S; Roland JT
J Neurosurg; 2011 Oct; 115(4):827-34. PubMed ID: 21761973
[TBL] [Abstract][Full Text] [Related]
16. Beneficial auditory and cognitive effects of auditory brainstem implantation in children.
Colletti L
Acta Otolaryngol; 2007 Sep; 127(9):943-6. PubMed ID: 17712673
[TBL] [Abstract][Full Text] [Related]
17. Auditory brainstem implants for hearing rehabilitation in NF2-schwannomatosis: A systematic review and single-arm meta-analysis.
Wang B; Yan M; Liu C; Yang Z; Wang X; Zhao F; Wang Z; Li P; Wang Y; Li S; Liu G; Liu P
NeuroRehabilitation; 2024; 54(2):213-225. PubMed ID: 38427506
[TBL] [Abstract][Full Text] [Related]
18. Options and strategies for hearing restoration in pediatric neurofibromatosis type 2.
Mahboubi H; Slattery WH; Mehta GU; Lekovic GP
Childs Nerv Syst; 2020 Oct; 36(10):2481-2487. PubMed ID: 32564156
[TBL] [Abstract][Full Text] [Related]
19. Ipsilateral Cochlear Implantation in the Presence of Observed and Irradiated Vestibular Schwannomas.
Urban MJ; Moore DM; Kwarta K; Leonetti J; Rajasekhar R; Gluth MB; Wiet RM
Ann Otol Rhinol Laryngol; 2020 Dec; 129(12):1229-1238. PubMed ID: 32551844
[TBL] [Abstract][Full Text] [Related]
20. Hearing restoration in NF2 patients and patients with vestibular schwannoma in the only hearing ear: report of two cases.
Ozdek A; Bayır O; Dönmez T; Ozışık P; Sahin M; Tulgar M; Tatar EÇ; Korkmaz MH
Am J Otolaryngol; 2014; 35(4):538-41. PubMed ID: 24746329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
